Company / Profit Margin
Silo Pharma, Inc. Profit Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-6092.6%
FY2025
5-year range
-6092.6% / -2389.7%
FY2021-FY2025
Trend
-18.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -5420.9% to -6092.6% over the past 2 years.
Based on SEC 10-K filings.
-6092.6% in FY2025 with a 5-year CAGR of -3594.9%.
Declined from -5420.9% to -6092.6% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -3594.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 18.7% year-over-year.
- Peak profit margin was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -6092.6% | -18.7% |
| FY2024 | -5132.6% | +5.3% |
| FY2023 | -5420.9% | -117.0% |
| FY2020 | -2497.7% | -4.5% |
| FY2019 | -2389.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026